open access
Vol 62, No 4 (2012)
Review paper
Published online: 2012-09-01
Get Citation
Effects of hypoxia on tumor metabolism
, ,
Nowotwory. Journal of Oncology 2012;62(4):283-290.
open access
Vol 62, No 4 (2012)
Review article
Published online: 2012-09-01
Abstract
A major feature of solid tumors is hypoxia which affects cancer biology, increases resistance to treatment and patient
prognosis. Adaptive responses of cells to hypoxia include stimulation of angiogenesis, erythropoiesis and alteration
of cellular metabolism. Cancer cells are characterized by reprogramming of metabolism leading to increased glycolysis,
attenuation of oxidative phosphorylation and de novo synthesis of fatty acids. Hypoxia-induced activation of
hypoxia-inducible factor (HIF-1) plays an important role in the reprogramming of cancer metabolism by activating
transcription of genes encoding glucose transporters and glycolytic enzymes leading to increased glucose uptake,
and pyruvate dehydrogenase kinase 1 (PDK1), which diminished mitochondrial respiration. The shift from oxidative
to glycolytic metabolism allows maintenance of redox homeostasis, survival and continued proliferation of cancer
cells under hypoxic conditions.
prognosis. Adaptive responses of cells to hypoxia include stimulation of angiogenesis, erythropoiesis and alteration
of cellular metabolism. Cancer cells are characterized by reprogramming of metabolism leading to increased glycolysis,
attenuation of oxidative phosphorylation and de novo synthesis of fatty acids. Hypoxia-induced activation of
hypoxia-inducible factor (HIF-1) plays an important role in the reprogramming of cancer metabolism by activating
transcription of genes encoding glucose transporters and glycolytic enzymes leading to increased glucose uptake,
and pyruvate dehydrogenase kinase 1 (PDK1), which diminished mitochondrial respiration. The shift from oxidative
to glycolytic metabolism allows maintenance of redox homeostasis, survival and continued proliferation of cancer
cells under hypoxic conditions.
Abstract
A major feature of solid tumors is hypoxia which affects cancer biology, increases resistance to treatment and patient
prognosis. Adaptive responses of cells to hypoxia include stimulation of angiogenesis, erythropoiesis and alteration
of cellular metabolism. Cancer cells are characterized by reprogramming of metabolism leading to increased glycolysis,
attenuation of oxidative phosphorylation and de novo synthesis of fatty acids. Hypoxia-induced activation of
hypoxia-inducible factor (HIF-1) plays an important role in the reprogramming of cancer metabolism by activating
transcription of genes encoding glucose transporters and glycolytic enzymes leading to increased glucose uptake,
and pyruvate dehydrogenase kinase 1 (PDK1), which diminished mitochondrial respiration. The shift from oxidative
to glycolytic metabolism allows maintenance of redox homeostasis, survival and continued proliferation of cancer
cells under hypoxic conditions.
prognosis. Adaptive responses of cells to hypoxia include stimulation of angiogenesis, erythropoiesis and alteration
of cellular metabolism. Cancer cells are characterized by reprogramming of metabolism leading to increased glycolysis,
attenuation of oxidative phosphorylation and de novo synthesis of fatty acids. Hypoxia-induced activation of
hypoxia-inducible factor (HIF-1) plays an important role in the reprogramming of cancer metabolism by activating
transcription of genes encoding glucose transporters and glycolytic enzymes leading to increased glucose uptake,
and pyruvate dehydrogenase kinase 1 (PDK1), which diminished mitochondrial respiration. The shift from oxidative
to glycolytic metabolism allows maintenance of redox homeostasis, survival and continued proliferation of cancer
cells under hypoxic conditions.
Get Citation
About this articleTitle
Effects of hypoxia on tumor metabolism
Journal
Nowotwory. Journal of Oncology
Issue
Article type
Review paper
Pages
283-290
Published online
2012-09-01
Page views
1566
Article views/downloads
7621
Bibliographic record
Nowotwory. Journal of Oncology 2012;62(4):283-290.
Authors
Katarzyna Błaszczak-Świątkiewicz
Paulina Olszewska
Elżbieta Mikiciuk-Olasik